New eyelid wipe aims to soothe dry eyes

NCT ID NCT06400459

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new medicated eyelid wipe called IVW-1001 in 150 adults with dry eye disease. Participants used either a low dose, a higher dose, or a placebo wipe. The goal was to see if the wipe is safe and can improve tear production and eye comfort.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

IVW-1001 (a drug applied via eyelid wipe)

What this could lead to

If it works, this could provide a new, easy-to-use treatment option for people with dry eye disease.

What could go wrong

This is an early-phase trial with only 150 participants, so results may not apply to everyone. The treatment is still being tested for safety and effectiveness.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Houston Eye Associates

    Houston, Texas, 77025, United States